Loading...
Last update:  September 5, 2010
08:57 +1GMT

Allergenic Molecule  Ara h 2  
Entry date
September 24, 2002  12:00 +1GMT
Last update
September 3, 2010  21:00 +1GMT
Allergome Code
51
Name
Ara h 2
Previous Names
Ara h II
Common Names
Conglutin, f423
Biological Function
Trypsin Inhibitors
Isoforms, Variants,
Epitopes
Ara h 2.0101, Ara h 2.0102, Ara h 2.0201, Ara h 2.0202
Links to Molecule
Sequences
Ara h 2 - AX148738 - NCBI, Ara h 2 - AY581854 - NCBI, Ara h 2 - C0LJJ1 - UNIPROT, Ara h 2 - EF080817 - NCBI, Ara h 2 - Q6PSU2 - UNIPROT, Ara h 2.0101 - Q6PSU2 - UNIPROT, Ara h 2.0201 - Q6PSU2 - UNIPROT
Links to AllFam
Prolamin superfamily
Sources
Arachis hypogaea, Groundnut, Legumes, Leguminosae, Peanuts, Plants
... other Source Terms in available Languages ->
Links to Source
Taxonomy
Ara h - 26463 - ITIS, Ara h - 3818 - NCBI, Ara h - 3818 - UniProt-Taxonomy, Ara h - Wikipedia
Links to Source Images
Ara h - bogaruhr04, Ara h - cornell23, Ara h - plantatlas07, Ara h - tipogov56, Ara h - viridis18
Tissues
Seed
Routes of Exposure
Ingestion
Epidemiology from
Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
3.2.1 - Source Sensitized (IgE)2010SwedenIgE10053.00020100212, Asarnoj A
4.1.5 - Heterologous Source Sensitized (IgE)2010SwedenIgE500.00020100212, Asarnoj A
4.1.6 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE372.70220090826, Ebo DG
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE220.00020091121, Ebo DG
4.1.6 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009ItalyIgE210.00020090808, Krause S
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE200.00020091121, Ebo DG
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE205.00020091005, Ott H
5.1.1 - Source Exposed (Symptoms)2007FranceIgE4793.60020071022, Bernard H
5.7.2 - Source Exposed (Provocation Test - Ingestion)2007NetherlandsIgE20100.00020070615, Flinterman AE
5.7.2 - Source Exposed (Provocation Test - Ingestion)2007NetherlandsSPT9100.00020070615, Flinterman AE
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2006FranceIgE30100.00020060630, Astier C
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2006FranceSPT30100.00020060630, Astier C
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2006GermanyIgE1662.50020060711, Lin J
5.3.1 - Source Exposed (Symptoms, IgE)2004AustraliaIgE7081.40020040904, Hales BJ
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2004NetherlandsIgE (IB)3281.20020040416, Koppelman SJ
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2004Netherlands / SwitzerlandIgE1741.20020041204, Mittag D
5.2.1 - Source Exposed (Symptoms, SPT)2003FranceIgE5888.00020031107, Bernard H
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)1999Not DefinedIgE (IB)4085.0001999, Kleber-Janke T
Reagents
1) Molecule
- Indoor Biotechnologies
4) Diagnostic (in vitro)
- Phadia - VBC-Genomics
References
Biochemistry / Structure / Function
2010:
20100706, Koppelman SJ - 20100622, Johnson PE - 20100621, Radosavljevic J - 20100614, Liu H - 20100506, Schmidt H - 20100311, Faeste CK
2009:
20091125, Li J - 20090808, Dooper MM - 20090717, Schmidt H - 20090712, Albrecht M - 20090522, Bernard H - 20090511, Porterfield HS - 20090218, Chassaigne H
2008:
20081203, Stevenson SE - 20081114, Ramos ML - 20081114, Chu Y - 20081105, Kopper RA - 20081103, Clare DA - 20081028, Ivanciuc O - 20081027, Ivanciuc O
... complete Reference listing ->

Molecular Biology
2010:
20100621, Radosavljevic J
2009:
20090811, Roesler E
2008:
20081203, Stevenson SE - 20081114, Chu Y
2007:
20070905, Dodo HW - 20070822, Glenting J - 20070430, Kang IH
2006:
20060630, Astier C
2005:
20050929, King N - 20050923, Sforza S - 20050810, Yan YS - 20050125, Dodo H
2004:
20040904, Hales BJ - 20040611, Stephan O
2003:
20031017, Lehmann K
2001:
2001, Viquez OM
2000:
2000, Kleber-Janke T
1999:
1999, Kleber-Janke T
1997:
1997, Stanley JS

Immunochemistry / Allergenicity
2010:
20100621, Radosavljevic J - 20100614, Liu H
2009:
20090808, Dooper MM - 20090717, Schmidt H - 20090712, Albrecht M - 20090622, Ocmant A - 20090615, Blanc F - 20090522, Bernard H - 20090218, Chassaigne H
2008:
20081114, Chu Y - 20081103, Clare DA - 20081028, Ivanciuc O - 20080826, Marsh J - 20080805, Guo B - 20080122, Riecken S
2007:
20071112, El-Khouly F - 20071022, Bernard H - 20071004, Gubesch M - 20070907, Lin J - 20070905, Dodo HW
... complete Reference listing ->

Immune-mechanisms / Genetics
2010:
20100113, Flinterman AE
2009:
20090703, Jones SM
2005:
20050929, King N
2004:
20041207, Glaspole IN
2003:
2003, Turcanu V
1998:
1998, van Reijsen FC
1994:
1994, Dorion BJ

Detection - Source Extracts, Food Products, Drug Preparations
2009:
20091223, Schmitt DA - 20091029, Krause S - 20090717, Schmidt H - 20090528, Scaravelli E
2008:
20081203, Stevenson SE - 20081114, Chu Y - 20080805, Guo B - 20080218, Careri M
2007:
20071004, Gubesch M - 20070927, Careri M - 20070531, Kang IO - 20070518, Chassaigne H - 20070503, Chassaigne H - 20070430, Kang IH - 20070420, McDermott RA
2006:
20061128, Kaul S - 20060824, Thottingal TB
2005:
20050923, Sforza S - 20050410, Poms RE - 20050201, Schmitt DA
... complete Reference listing ->

Detection - Allergy Diagnostic and Immunotherapeutic Products
1995:
1995, Hefle SL

Detection - Source Tissues
2007:
20070905, Dodo HW - 20070430, Kang IH

Detection - Body Biodistribution
2001:
2001, Vadas P

Epidemiology
2009:
20090826, Ebo DG
1999:
1999, Kleber-Janke T

Diagnosis
2010:
20100531, Thompson JC - 20100316, Cabanos C - 20100212, Asarnoj A - 20100101, Nicolau N
2009:
20091121, Ebo DG - 20091005, Ott H - 20090826, Ebo DG - 20090808, Krause S - 20090622, Ocmant A - 20090615, Blanc F - 20090505, Vidal C - 20090210, Yagami A
2008:
20081230, Adachi A
2007:
20070615, Flinterman AE - 20070420, McDermott RA
2006:
20061223, Peters KA - 20060711, Lin J - 20060630, Astier C
2005:
20051008, Shreffler WG - 20050517, Palmer GW
... complete Reference listing ->

Experimental Model - Allergic Immune Response
2009:
20090811, Roesler E
2008:
20080211, Proust B
2006:
20061223, Adel-Patient K - 20061212, de Jonge JD

Experimental Model - Ingestion-induced Diseases
2005:
20050501, van Wijk F - 20050410, Adel-Patient K
2004:
20041224, van Wijk F - 20040907, Van Wijk F
2003:
20030713, Li XM - 2003, Li XM
2000:
2000, Li XM
1999:
1999, Roy K - 1999, Li X

Experimental Model - Skin-induced Diseases
2006:
20061223, Adel-Patient K

Review, Editorial, Report Citations, Other Resources
2010:
20100721, Stevenson SE - 20100611, Lucas JM - 20100610, Kemp A - 20100527, Scurlock AM - 20100430, Wang J - 20100412, Karp CL - 20100312, Wang J - 20100226, Turcanu V - 20100216, Rance F - 20100101, Sicherer SH
2009:
20091231, Sicherer SH - 20091210, Thyagarajan A - 20091210, Jappe U - 20091204, Harrer A - 20091121, Knol EF - 20091119, Riascos JJ - 20091008, Yano H - 20091006, Alessandri C - 20091005, Ladics GS - 20090809, Jacquenet S
... complete Reference listing ->
Developed by
Panservice